Mesalazine enteric-coated tablets are intestinal anti-inflammatory drugs and do not have a direct hemostatic effect. The indications for mesalazine enteric coated tablets include ulcerative colitis and segmental ileitis. And the early intestinal mucosa of the above diseases shows congestion and loss of normal vascular pattern; specifically, hemorrhagic inflammation with loss of normal vascular pattern, petechial hemorrhage and bleeding. Most of the mesalazine enteric-coated tablets can reach the colon directly after taking, act on the inflamed mucosa, inhibit the synthesis of prostaglandins and the formation of inflammatory mediators leukotrienes that cause inflammation, and have significant anti-inflammatory effect on the inflammation of the intestinal wall, and are particularly effective on the inflammatory intestinal wall connective tissues. Therefore, mesalazine enteric-coated tablets is through the reduction of the inflammatory reaction of the intestinal mucosa, thereby reducing the vascular destruction of the intestinal mucosa, indirectly achieve a certain degree of hemostasis. If you need to use mesalazine enteric-coated tablets, you need to be under the supervision of a doctor.